Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
Main Authors: | Ikeda, Hiroaki, Ueno, Hiroaki, Kawamura, Ayumi, Imai, Naoko, Okamoto, Sachiko, Mineno, Junichi, Takesako, Kazutoh, Shiku, Hiroshi |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288585/ |
Similar Items
-
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
by: Okamoto, Sachiko, et al.
Published: (2012) -
In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
by: Ikeda, Hiroaki, et al.
Published: (2013) -
Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
by: Wang, Linan, et al.
Published: (2016) -
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
by: Shiku, H, et al.
Published: (2014) -
Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
by: Asai, Hiroaki, et al.
Published: (2014)